↓ Skip to main content

A Randomized Controlled Trial to Prevent Depression and Ameliorate Insulin Resistance in Adolescent Girls at Risk for Type 2 Diabetes

Overview of attention for article published in Annals of Behavioral Medicine, June 2016
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
222 Mendeley
Title
A Randomized Controlled Trial to Prevent Depression and Ameliorate Insulin Resistance in Adolescent Girls at Risk for Type 2 Diabetes
Published in
Annals of Behavioral Medicine, June 2016
DOI 10.1007/s12160-016-9801-0
Pubmed ID
Authors

Lauren B. Shomaker, Nichole R. Kelly, Courtney K. Pickworth, Omni L. Cassidy, Rachel M. Radin, Lisa M. Shank, Anna Vannucci, Katherine A. Thompson, Sara A. Armaiz-Flores, Sheila M. Brady, Andrew P. Demidowich, Ovidiu A. Galescu, Amber B. Courville, Cara Olsen, Kong Y. Chen, Eric Stice, Marian Tanofsky-Kraff, Jack A. Yanovski

Abstract

Prospective data suggest depressive symptoms worsen insulin resistance and accelerate type 2 diabetes (T2D) onset. We sought to determine whether reducing depressive symptoms in overweight/obese adolescents at risk for T2D would increase insulin sensitivity and mitigate T2D risk. We conducted a parallel-group, randomized controlled trial comparing a 6-week cognitive-behavioral (CB) depression prevention group with a 6-week health education (HE) control group in 119 overweight/obese adolescent girls with mild-to-moderate depressive symptoms (Center for Epidemiological Studies-Depression Scale [CES-D] ≥16) and T2D family history. Primary outcomes were baseline to post-intervention changes in CES-D and whole body insulin sensitivity index (WBISI), derived from 2-h oral glucose tolerance tests. Outcome changes were compared between groups using ANCOVA, adjusting for respective baseline outcome, puberty, race, facilitator, T2D family history degree, baseline age, adiposity, and adiposity change. Multiple imputation was used for missing data. Depressive symptoms decreased (p < 0.001) in CB and HE from baseline to posttreatment, but did not differ between groups (ΔCESD = -12 vs. -11, 95 % CI difference = -4 to +1, p = 0.31). Insulin sensitivity was stable (p > 0.29) in CB and HE (ΔWBISI = 0.1 vs. 0.2, 95 % CI difference = -0.6 to +0.4, p = 0.63). Among all participants, reductions in depressive symptoms were associated with improvements in insulin sensitivity (p = 0.02). Girls at risk for T2D displayed reduced depressive symptoms following 6 weeks of CB or HE. Decreases in depressive symptoms related to improvements in insulin sensitivity. Longer-term follow-up is needed to determine whether either program causes sustained decreases in depressive symptoms and improvements in insulin sensitivity. The trial was registered with clinicaltrials.gov (NCT01425905).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 222 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 222 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 30 14%
Student > Bachelor 30 14%
Researcher 24 11%
Student > Ph. D. Student 19 9%
Student > Doctoral Student 14 6%
Other 32 14%
Unknown 73 33%
Readers by discipline Count As %
Psychology 40 18%
Medicine and Dentistry 32 14%
Nursing and Health Professions 25 11%
Social Sciences 9 4%
Biochemistry, Genetics and Molecular Biology 8 4%
Other 22 10%
Unknown 86 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 June 2016.
All research outputs
#20,334,427
of 22,879,161 outputs
Outputs from Annals of Behavioral Medicine
#1,338
of 1,390 outputs
Outputs of similar age
#305,295
of 352,770 outputs
Outputs of similar age from Annals of Behavioral Medicine
#19
of 20 outputs
Altmetric has tracked 22,879,161 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,390 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.5. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,770 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.